The Effect of Different Treatment Modalities of Class II Malocclusion on Upper Third Molars.

NCT ID: NCT06098885

Last Updated: 2023-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-04

Study Completion Date

2023-06-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

What is the effect of the different treatment modalities (distalization versus upper premolar extraction) of class II malocclusion on the position, inclination and incidence of impaction of the upper third molars?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

What is the effect of the different treatment modalities (distalization versus upper premolar extraction) of class II malocclusion on the position, inclination and incidence of impaction of the upper third molars? Pico P: Adolescent patients with class II malocclusion having bilateral developing upper third molars.

I: bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

C: distalization orthodontic treatment. O: Primary: angulation of the maxillary third molars.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Third Molar Impaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

extraction treatment

patients treated with bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

extraction orthodontic treatment

Intervention Type OTHER

bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

distalization treatment

patients treated by distalization orthodontic treatment.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

extraction orthodontic treatment

bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescent males and females (16 -18 years) with Bilaterally developing maxillary third molars. Not more than two thirds of the root development of the third molars had taken place.
* Class II malocclusion cases that were treated by 1) maxillary premolar extraction with a moderate anchorage requirement and achieved full unit class II molar relationship or 2) Distalization treatment plan and class I molar relationship was achieved.
* Patients with high-quality pre- and post-treatment radiographs.
* Normal or increased vertical dimension.

Exclusion Criteria

* Maxillary Premolar extraction cases requiring maximum anchorage preparation.
* Low vertical dimension.
* Patients without dentofacial deformities, severe facial asymmetries, microdontia or hypodontia.
Minimum Eligible Age

16 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amira Aboalnaga

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amira Aboalnaga

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEBD-CU-2021-9-7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.